HIV and AIDS Trial, Recruiting NCT06408142 Sponsor: Johns Hopkins University Condition: HIV and AIDS
Back to Hiv Aids

HIV and AIDS Trial, Recruiting

NCT06408142
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For patients visiting the Emergency Department:

  • People aged 12 years or older who are attending the Emergency Department in South Africa
  • For the part of the trial involving PrEP (a medication that helps prevent HIV), people who meet the medical requirements for PrEP and do not have conditions that would make PrEP unsuitable for them — such as kidney disease, current signs or symptoms of HIV infection, or already being on PrEP

For healthcare staff:

  • Nurses, doctors, or advanced practice providers who regularly work in the Emergency Department at one of the trial locations
  • Staff members who agree to take part in a recorded in-depth interview and/or a survey

Who may not be able to join:

For patients:

  • People who are unable to give written consent — for example, those with a reduced level of consciousness due to head injury or alcohol or substance use
  • People who are assessed as critically ill (given an "emergent" triage rating)
  • People who do not speak English, Afrikaans, or Xhosa (the languages spoken by the study team)

For healthcare staff:

  • Staff members who have already been interviewed through another trial site (if they work at more than one location)
  • Staff members who do not agree to take part in an interview or survey

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Bhakti Hansoti, MD, Johns Hopkins University

Phone: 3195419183

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
19 January 2026
Est. completion
1 December 2027

Where this trial is recruiting

🇿🇦 South Africa

Primary endpoints

The proportion of potentially PrEP eligible patients in the ED

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov